Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |